Health IT

ExchangeRight's latest fund sold out fast, signaling a major investor shift toward sophisticated tax-deferred strategies and recession-proof real estate.

For a teen with rare genetic conditions, a sunken chest was a daily struggle. A pioneering surgery didn't just fix it—it gave him a new life.

Neurovascular giant Balt deepens its Irvine roots with a new facility, a $400M investment, and plans for 700 jobs to accelerate stroke-fighting tech.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

An award-winning technology is transforming how hospitals treat a deadly diabetic complication in children, minimizing errors and improving patient safety.

Health AI firm Vi secures unicorn status with a $145M deal while launching new AI agents. But can its vision of 'health abundance' overcome ethical hurdles?

A new report reveals 90% of employees use general AI for benefits, but inaccuracies lead to steep costs, creating a liability crisis for employers.

The AMA appoints Dr. John Wigneswaran, a physician-exec from Walmart and UnitedHealth, signaling a strategic shift toward corporate-style operations.

A new state security certification for PARiConnect is set to streamline access to vital psychological and educational assessments for Texas students.

Renowned cancer researcher Dr. Dario Altieri leaves a top CEO post to return to the lab at Jefferson, signaling a major shift in Philadelphia's science scene.

Verint's Calabrio WFM gains a key Microsoft certification, promising streamlined AI deployment and new agent autonomy in healthcare and financial services.

Thalo Labs secures investment from Suffolk Technologies to deploy AI diagnostics, empowering HVAC techs and revolutionizing building maintenance.

In an era of rampant data breaches, the in-home care provider's new 'gold standard' certification raises the bar for protecting sensitive patient data.

A new survey reveals 96% of food bank clients are cutting back on food. With rising costs and massive federal aid cuts, Silicon Valley faces a crisis.

Amplexd Therapeutics launches a Phase 2 trial in Hong Kong for a novel, non-surgical HPV therapy, offering hope to millions in diagnostic limbo.

With a novel two-in-one device and a $41M funding boost, Cagent Vascular is poised to challenge the standard of care for complex calcified arteries.

A new study reveals a sharp drop in prescription fills at just $35, highlighting a critical affordability crisis that even insured patients can't escape.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

Nourish lands $100M to expand its AI-powered metabolic clinic, blending dietitian care with technology to reverse chronic disease and cut healthcare costs.

A new partnership embeds specialty drug ordering into clinic software, promising to boost efficiency and patient care in the booming infusion market.